Browse By Assay Result Page of OvirusTdb

The total number record retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_133Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI1% cancer cell deathNoNoNA No responseNANANANA26524593
OV_134Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI1% cancer cell deathNoNoNA No responseNANANANA26524593
OV_135Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI25% cancer cell deathNoNoNA No responseNANANANA26524593
OV_136Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI16% cancer cell deathNoNoNA No responseNANANANA26524593
OV_137Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI1% cancer cell deathNoNoNA No responseNANANANA26524593
OV_138Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI5% cancer cell deathNoNoNA No responseNANANANA26524593
OV_139Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI20% cancer cell deathNoNoNA No responseNANANANA26524593
OV_140Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI32% cancer cell deathNoNoNA No responseNANANANA26524593
OV_141Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI3% cancer cell deathNoNoNA No responseNANANANA26524593
OV_142Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_143Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI30% cancer cell deathNoNoNA No responseNANANANA26524593
OV_144Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI32% cancer cell deathNoNoNA No responseNANANANA26524593
OV_145Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI15% cancer cell deathNoNoNA No responseNANANANA26524593
OV_146Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_147Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI33% cancer cell deathNoNoNA No responseNANANANA26524593
OV_148Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_149Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI20% cancer cell deathNoNoNA No responseNANANANA26524593
OV_150Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI26% cancer cell deathNoNoNA No responseNANANANA26524593
OV_151Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI49% cancer cell deathNoNoNA No responseNANANANA26524593
OV_152Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI98% cancer cell deathNoNoNA No responseNANANANA26524593
OV_153Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI25% cancer cell deathNoNoNA No responseNANANANA26524593
OV_154Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI40% cancer cell deathNoNoNA No responseNANANANA26524593
OV_155Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI54% cancer cell deathNoNoNA No responseNANANANA26524593
OV_156Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI58% cancer cell deathNoNoNA No responseNANANANA26524593
OV_157Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI28% cancer cell deathNoNoNA No responseNANANANA26524593
OV_158Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI45% cancer cell deathNoNoNA No responseNANANANA26524593
OV_159Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI50% cancer cell deathNoNoNA No responseNANANANA26524593
OV_160Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI58% cancer cell deathNoNoNA No responseNANANANA26524593
OV_161Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI30% cancer cell deathNoNoNA No responseNANANANA26524593
OV_162Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI40% cancer cell deathNoNoNA No responseNANANANA26524593
OV_163Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 2 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI50% cancer cell deathNoNoNA No responseNANANANA26524593
OV_164Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with tubacin - 5 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI70% cancer cell deathNoNoNA No responseNANANANA26524593
OV_165Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁷ MOI5% cancer cell deathNoNoNA No responseNANANANA26524593
OV_166Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁷ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_167Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁷ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_168Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI9% cancer cell deathNoNoNA No responseNANANANA26524593
OV_169Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI6% cancer cell deathNoNoNA No responseNANANANA26524593
OV_170Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁶ MOI3% cancer cell deathNoNoNA No responseNANANANA26524593
OV_171Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI15% cancer cell deathNoNoNA No responseNANANANA26524593
OV_172Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI10% cancer cell deathNoNoNA No responseNANANANA26524593
OV_173Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁵ MOI5% cancer cell deathNoNoNA No responseNANANANA26524593
OV_174Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI40% cancer cell deathNoNoNA No responseNANANANA26524593
OV_175Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI44% cancer cell deathNoNoNA No responseNANANANA26524593
OV_176Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻⁴ MOI43% cancer cell deathNoNoNA No responseNANANANA26524593
OV_177Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI49% cancer cell deathNoNoNA No responseNANANANA26524593
OV_178Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI46% cancer cell deathNoNoNA No responseNANANANA26524593
OV_179Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻³ MOI42% cancer cell deathNoNoNA No responseNANANANA26524593
OV_180Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_181Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_182Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻² MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_183Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_184Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_185Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3⁻¹ MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_186Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI51% cancer cell deathNoNoNA No responseNANANANA26524593
OV_187Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_188Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay1 MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_189Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterYesNoNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI54% cancer cell deathNoNoNA No responseNANANANA26524593
OV_190Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 1 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI52% cancer cell deathNoNoNA No responseNANANANA26524593
OV_191Herpes simplex virusrQNestin34.5DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and ICP6 gene, re-addition of 34.5 gene under nestin promoterNoVirus in combination with CI994 - 3 micromolar starting at 14 hours before infectionNoNAHuman glioblastoma astrocytoma cell lineU251NANALDH cytotoxicity assay3 MOI60% cancer cell deathNoNoNA No responseNANANANA26524593
OV_323Canine parvovirusCPV2.NS1DNAParoviridaeCPV genome expressing non-structural protein (NS1)YesNoNoNCCS (National Centre for Cell Science, Pune, India)Human cervical cancer cell lineHeLadensity of E+4 to E+5 cells/well in 120 microlitres of culture mediumNALDH assayNA9% cancer cell death at 24 hoursNoNoNA No responseNAApoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9NANA26555166
OV_324Canine parvovirusCPV2.NS1DNAParoviridaeCPV genome expressing non-structural protein (NS1)YesNoNoNCCS (National Centre for Cell Science, Pune, India)Human cervical cancer cell lineHeLadensity of E+4 to E+5 cells/well in 120 microlitres of culture mediumNALDH assayNA18% cancer cell death at 48 hoursNoNoNA No responseNAApoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9NANA26555166
OV_1842Herpes simplex virusNV1023DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.01 MOI100% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1843Herpes simplex virusNV1024DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.01 MOI100% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1844Herpes simplex virusNV1025DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.01 MOI80% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1845Herpes simplex virusNV1026DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.01 MOI70% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1846Herpes simplex virusNV1027DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.1 MOI90% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1847Herpes simplex virusNV1028DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.1 MOI90% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1848Herpes simplex virusNV1029DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.1 MOI80% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1849Herpes simplex virusNV1030DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay0.1 MOI60% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1850Herpes simplex virusNV1031DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay1 MOI70% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1851Herpes simplex virusNV1032DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay1 MOI65% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1852Herpes simplex virusNV1033DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay1 MOI50% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1853Herpes simplex virusNV1034DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineHs766T2.0E+4 cells per wellNALDH release assay1 MOI20% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1854Herpes simplex virusNV1035DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.1 MOINo cell killing after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1855Herpes simplex virusNV1036DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.1 MOINo cell killing after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1856Herpes simplex virusNV1037DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.1 MOINo cell killing after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1857Herpes simplex virusNV1038DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.1 MOINo cell killing after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1858Herpes simplex virusNV1039DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.2 MOINo cell killing after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1859Herpes simplex virusNV1040DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.2 MOINo cell killing after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1860Herpes simplex virusNV1041DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.2 MOI98% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1861Herpes simplex virusNV1042DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.2 MOINo cell killing after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1862Herpes simplex virusNV1043DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.4 MOINo cell killing after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1863Herpes simplex virusNV1044DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.4 MOINo cell killing after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1864Herpes simplex virusNV1045DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.4 MOINo cell killing after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1865Herpes simplex virusNV1046DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.4 MOINo cell killing after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1866Herpes simplex virusNV1047DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.8 MOINo cell killing after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1867Herpes simplex virusNV1048DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.8 MOINo cell killing after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1868Herpes simplex virusNV1049DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.8 MOINo cell killing after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1869Herpes simplex virusNV1050DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay0.8 MOI90% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1870Herpes simplex virusNV1051DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay1.6 MOINo cell killing after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1871Herpes simplex virusNV1052DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay1.6 MOI90% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1872Herpes simplex virusNV1053DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay1.6 MOI90% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1873Herpes simplex virusNV1054DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay1.6 MOI80% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1874Herpes simplex virusNV1055DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay3.2 MOINo cell killing after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1875Herpes simplex virusNV1056DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay3.2 MOI90% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1876Herpes simplex virusNV1057DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay3.2 MOI80% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1877Herpes simplex virusNV1058DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell lineMIA paCa-22.0E+4 cells per wellNALDH release assay3.2 MOI80% cell survival after day 7NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1878Herpes simplex virusNV1059DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.012 MOI90% cell survival after day 1NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1879Herpes simplex virusNV1060DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.012 MOI90% cell survival after day 3NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009
OV_1880Herpes simplex virusNV1061DNAHerpesviridaeInsertion of HSV-2 DNA at UL and US sequences, deletion of ICP4 and gamma 34.5 geneYesNoNoATCCHuman pancreatic cancer cell linePANC-12.0E+4 cells per wellNALDH release assay0.012 MOI90% cell survival after day 5NoNoNA No responseNAInduction of apoptosis by the virusNANA20629009